Search Results - "Marroquin, Oscar C"

Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease by Carson, Jeffrey L., MD, Brooks, Maria Mori, PhD, Abbott, J. Dawn, MD, Chaitman, Bernard, MD, Kelsey, Sheryl F., PhD, Triulzi, Darrell J., MD, Srinivas, Vankeepuram, MD, Menegus, Mark A., MD, Marroquin, Oscar C., MD, Rao, Sunil V., MD, Noveck, Helaine, MPH, Passano, Elizabeth, MS, Hardison, Regina M., MS, Smitherman, Thomas, MD, Vagaonescu, Tudor, MD, Wimmer, Neil J., MD, Williams, David O., MD

“…Background Prior trials suggest it is safe to defer transfusion at hemoglobin levels above 7 to 8 g/dL in most patients. Patients with acute coronary syndrome…”
Get full text

Is LDL cholesterol associated with long-term mortality among primary prevention adults? A retrospective cohort study from a large healthcare system by Kip, Kevin E, Diamond, David, Mulukutla, Suresh, Marroquin, Oscar C

“…ObjectivesAmong primary prevention-type adults not on lipid-lowering therapy, conflicting results exist on the relationship between low-density lipoprotein…”
Get full text

Five-Year Follow-Up of Patients Treated for Coronary Artery Disease in the Face of an Increasing Burden of Co-Morbidity and Disease Complexity (from the NHLBI Dynamic Registry) by Bortnick, Anna E., MD, PhD, Epps, Kelly C., MD, Selzer, Faith, PhD, Anwaruddin, Saif, MD, Marroquin, Oscar C., MD, Srinivas, Vankeepuram, MBBS, MS, Holper, Elizabeth M., MD, Wilensky, Robert L., MD

“…Management of coronary artery disease (CAD) has evolved over the past decade, but there are few prospective studies evaluating long-term outcomes in a…”
Get full text

Impact of Chronic Kidney Disease and Anemia on Outcomes After Percutaneous Coronary Revascularization by Cilia, Lindsey, Sharbaugh, Michael, Marroquin, Oscar C., Toma, Catalin, Smith, Conrad, Thoma, Floyd, Lee, Joon, Mulukutla, Suresh R.

“…Few studies have evaluated outcomes after percutaneous coronary intervention (PCI) in patients with both anemia (hemoglobin < 12 g/dl in women; <13 in men) and…”
Get full text

Predictive model for severe COVID-19 using SARS-CoV-2 whole-genome sequencing and electronic health record data, March 2020-May 2021 by Zhu, Lei, Marsh, Jane W, Griffith, Marissa P, Collins, Kevin, Srinivasa, Vatsala, Waggle, Kady, Van Tyne, Daria, Snyder, Graham M, Phan, Tung, Wells, Alan, Marroquin, Oscar C, Harrison, Lee H

“…Objective We used SARS-CoV-2 whole-genome sequencing (WGS) and electronic health record (EHR) data to investigate the associations between viral genomes and…”
Get full text

A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications by Marroquin, Oscar C, Selzer, Faith, Mulukutla, Suresh R, Williams, David O, Vlachos, Helen A, Wilensky, Robert L, Tanguay, Jean-François, Holper, Elizabeth M, Abbott, J. Dawn, Lee, Joon S, Smith, Conrad, Anderson, William D, Kelsey, Sheryl F, Kip, Kevin E

“…In patients in a large registry who received coronary stents for off-label indications, there was no difference in mortality or rates of myocardial infarction…”
Get full text

Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients with Chronic Kidney Disease by Roberts, John K., MD, MS, Rao, Sunil V., MD, Shaw, Linda K., MS, Gallup, Dianne S., MS, Marroquin, Oscar C., MD, Patel, Uptal D., MD

“…Abstract Patients with chronic kidney disease (CKD) are at increased risk for cardiovascular disease and death, yet little data exists regarding the…”
Get full text

REMAP Periop: a randomised, embedded, multifactorial adaptive platform trial protocol for perioperative medicine to determine the optimal enhanced recovery pathway components in complex abdominal surgery patients within a US healthcare system by Holder-Murray, Jennifer, Esper, Stephen A, Althans, Alison R, Knight, Joshua, Subramaniam, Kathirvel, Derenzo, Joseph, Ball, Ryan, Beaman, Shawn, Luke, Charles, La Colla, Luca, Schott, Nicholas, Williams, Brian, Lorenzi, Elizabeth, Berry, Lindsay R, Viele, Kert, Berry, Scott, Masters, Miranda, Meister, Katie A, Wilkinson, Todd, Garrard, William, Marroquin, Oscar C, Mahajan, Aman

“…IntroductionImplementation of enhanced recovery pathways (ERPs) has resulted in improved patient-centred outcomes and decreased costs. However, there is a lack…”
Get full text

Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study) by Khandhar, Sameer J., MD, Yamamoto, Hirosada, MD, Teuteberg, Jeffrey J., MD, Shullo, Michael A., PharmD, Bezerra, Hiram G., MD, PhD, Costa, Marco A., MD, PhD, Selzer, Faith, PhD, Lee, Joon S., MD, Marroquin, Oscar C., MD, McNamara, Dennis M., MD, Mulukutla, Suresh R., MD, Toma, Catalin, MD

“…Background Optical coherence tomography (OCT) is a novel intravascular imaging modality with excellent spatial resolution. This study explored the utility of…”
Get full text

Clinical Utility of Regadenoson for Assessing Fractional Flow Reserve by Nair, Pradeep K., MD, Marroquin, Oscar C., MD, Mulukutla, Suresh R., MD, Khandhar, Sameer, MD, Gulati, Vijay, MD, Schindler, John T., MD, Lee, Joon S., MD

“…Objectives The aim of this study was to evaluate the efficacy of regadenoson, in comparison with adenosine, for assessing fractional flow reserve (FFR) of…”
Get full text

Strategies to Promote ResiliencY (SPRY): a randomised embedded multifactorial adaptative platform (REMAP) clinical trial protocol to study interventions to improve recovery after surgery in high-risk patients by Reitz, Katherine Moll, Seymour, Christopher W, Vates, Jennifer, Quintana, Melanie, Viele, Kert, Detry, Michelle, Morowitz, Michael, Morris, Alison, Methe, Barbara, Kennedy, Jason, Zuckerbraun, Brian, Girard, Timothy D, Marroquin, Oscar C, Esper, Stephen, Holder-Murray, Jennifer, Newman, Anne B, Berry, Scott, Angus, Derek C, Neal, Matthew

“…IntroductionAs the population ages, there is interest in strategies to promote resiliency, especially for frail patients at risk of its complications. The…”
Get full text

Extracorporeal Membrane Oxygenation for Advanced Refractory Shock in Acute and Chronic Cardiomyopathy by Bermudez, Christian A., MD, Rocha, Rodolfo V., MD, Toyoda, Yoshiya, MD, PhD, Zaldonis, Diana, MPH, BSN, Sappington, Penny L., MD, Mulukutla, Suresh, MD, Marroquin, Oscar C., MD, Toma, Catalin, MD, Bhama, Jay K., MD, Kormos, Robert L., MD

“…Background Extracorporeal membrane oxygenation (ECMO) has been used to obtain rapid resuscitation and stabilization in advanced refractory cardiogenic shock…”
Get full text

Depression, the metabolic syndrome and cardiovascular risk by Vaccarino, Viola, McClure, Candace, Johnson, B Delia, Sheps, David S, Bittner, Vera, Rutledge, Thomas, Shaw, Leslee J, Sopko, George, Olson, Marian B, Krantz, David S, Parashar, Susmita, Marroquin, Oscar C, Merz, C Noel Bairey

“…The relationship between depression and the metabolic syndrome is unclear, and whether metabolic syndrome explains the association between depression and…”
Get full text

Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography by LaFramboise, William A, Dhir, Rajiv, Kelly, Lori A, Petrosko, Patricia, Krill-Burger, John M, Sciulli, Christin M, Lyons-Weiler, Maureen A, Chandran, Uma R, Lomakin, Aleksey, Masterson, Robert V, Marroquin, Oscar C, Mulukutla, Suresh R, McNamara, Dennis M

“…More than a million diagnostic cardiac catheterizations are performed annually in the US for evaluation of coronary artery anatomy and the presence of…”
Get full text

Benefit of Long-Term Dual Anti-Platelet Therapy in Patients Treated With Drug-Eluting Stents: From the NHLBI Dynamic Registry by Mulukutla, Suresh R., MD, Marroquin, Oscar C., MD, Vlachos, Helen A., MSc, Selzer, Faith, PhD, Toma, Catalin, MD, Kip, Kevin E., PhD, Abbott, J. Dawn, MD, Holper, Elizabeth, MD, Lee, Joon S., MD, Khandhar, Sameer, MD, Kutcher, Michael, MD, Kelsey, Sheryl, PhD, Smith, Conrad, MD, Faxon, David, MD, Williams, David O., MD

“…The optimal duration of dual-antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation is an important, unanswered question. This study was…”
Get full text

Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment by Woltemate, Thomas J., Wadas, Richard J., McCreary, Erin K., Bariola, Ryan, Minnier, Tami, Marroquin, Oscar C., Schmidhofer, Mark, Albin, Debbie, Angus, Derek C., Yealy, Donald M.

“…Monoclonal antibody (mAb) therapy can improve coronavirus disease 2019 outcomes when infused early in select patients. We sought to rapidly create and…”
Get full text

Association between conventional or blue-light-filtering intraocular lenses and survival in bilateral cataract surgery patients by Griepentrog, John E., Zhang, Xianghong, Marroquin, Oscar C., Garver, Michael B., Rosengart, AnnaElaine L., Chung-Chou Chang, Joyce, Esfandiari, Hamed, Loewen, Nils A., Rosengart, Matthew R.

“…Circadian rhythms regulate adaptive alterations in mammalian physiology and are maximally entrained by the short wavelength blue spectrum; cataracts block the…”
Get full text

Assessment of P2Y12 Inhibitor Usage and Switching in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Revascularization by Kudaravalli, Mrudula, MD, Althouse, Andrew D., PhD, Marroquin, Oscar C., MD, Khandhar, Sameer J., MD, Sharbaugh, Michael S., MPH, Toma, Catalin, MD, Conrad Smith, A.J., MD, Schindler, John T., MD, Lee, Joon S., MD, Mulukutla, Suresh R., MD FACC FSCAI

“…Abstract Background Dual antiplatelet therapy is recommended for patients with acute coronary syndromes (ACS) that undergo percutaneous coronary intervention…”
Get full text

Incidence and Predictors of 30-Day Hospital Readmission Rate Following Percutaneous Coronary Intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry) by Ricciardi, Mark J., MD, Selzer, Faith, PhD, Marroquin, Oscar C., MD, Holper, Elizabeth M., MD, Venkitachalam, Lakshmi, PhD, Williams, David O., MD, Kelsey, Sheryl F., PhD, Laskey, Warren K., MD, MPH

“…Postdischarge outcomes after percutaneous coronary intervention (PCI) are important measurements of quality of care and complement in-hospital measurements. We…”
Get full text

Change in Albuminuria and eGFR Following Insulin Sensitization Therapy Versus Insulin Provision Therapy in the BARI 2D Study by August, Phyllis, Hardison, Regina M, Hage, Fadi G, Marroquin, Oscar C, McGill, Janet B, Rosenberg, Yves, Steffes, Michael, Wall, Barry M, Molitch, Mark

“…In the Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial, glycemic control with insulin-sensitization therapy was compared with…”
Get full text